Rheumatic Fever

Rheumatic Fever is a topic covered in the 5-Minute Clinical Consult.

To view the entire topic, please or .

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

-- The first section of this topic is shown below --

Basics

Description

  • Acute rheumatic fever (ARF) is an autoimmune, inflammatory response to infection with group A Streptococcus (GAS) that affects multiple organ systems.
  • Untreated acute disease can lead to chronic rheumatic heart disease (RHD).
  • Recurrence is common without adequate antibiotic treatment.

Pediatric Considerations
Most cases occur in children aged 5 to 15 years; rare in children <5 years (1)

Epidemiology

  • ARF and RHD are largely restricted to low-income countries and marginalized sections of wealthy countries.
  • Male = female; females more likely to develop chorea and RHD.
  • Endemic regions include South Pacific, indigenous populations of Australia and New Zealand, Africa, and Asia (2).

Incidence

  • Worldwide, incidence has been declining for 25 years. The large majority of new cases are in developing countries (2).
  • Mean worldwide incidence ranges from 8 to 51/100,000 school-aged children (1); in endemic regions, prevalence can be >1,000 cases per 100,000 people (2).
  • Incidence of ARF in the United States is approximately 0.6–3.4/100,000 school-aged children (2).

Prevalence

  • In developing areas, RHD affects >33 million people and is the leading cause of cardiovascular death during the first 5 decades of life.
  • Prevalence has been rising due to improved medical care and longer survival.

Etiology and Pathophysiology

  • ARF most commonly occurs 2 to 3 weeks after GAS pharyngitis infection, but GAS impetigo may also be a preceding infection.
  • Although pathogenicity is not completely understood, expert consensus implicates genetic and molecular mimicry leading to an inflammatory cascade as key to disease development.
  • Joint involvement is a likely result of immune complex accumulation.

Genetics

  • Susceptibility is associated with certain indigenous populations.
  • ARF is heritable, polygenic, and displays variable and incomplete penetrance.

Risk Factors

Poverty, household crowding, genetic susceptibility, ethnic predisposition, and social disadvantage are the strongest risk factors.

General Prevention

  • Primary prevention: Appropriate treatment of streptococcal infection prevents ARF in most cases (1).
  • Secondary prevention: long-term antibiotic prophylaxis (up to 5 to 10 years) to prevent recurrence (2)

-- To view the remaining sections of this topic, please or --

Basics

Description

  • Acute rheumatic fever (ARF) is an autoimmune, inflammatory response to infection with group A Streptococcus (GAS) that affects multiple organ systems.
  • Untreated acute disease can lead to chronic rheumatic heart disease (RHD).
  • Recurrence is common without adequate antibiotic treatment.

Pediatric Considerations
Most cases occur in children aged 5 to 15 years; rare in children <5 years (1)

Epidemiology

  • ARF and RHD are largely restricted to low-income countries and marginalized sections of wealthy countries.
  • Male = female; females more likely to develop chorea and RHD.
  • Endemic regions include South Pacific, indigenous populations of Australia and New Zealand, Africa, and Asia (2).

Incidence

  • Worldwide, incidence has been declining for 25 years. The large majority of new cases are in developing countries (2).
  • Mean worldwide incidence ranges from 8 to 51/100,000 school-aged children (1); in endemic regions, prevalence can be >1,000 cases per 100,000 people (2).
  • Incidence of ARF in the United States is approximately 0.6–3.4/100,000 school-aged children (2).

Prevalence

  • In developing areas, RHD affects >33 million people and is the leading cause of cardiovascular death during the first 5 decades of life.
  • Prevalence has been rising due to improved medical care and longer survival.

Etiology and Pathophysiology

  • ARF most commonly occurs 2 to 3 weeks after GAS pharyngitis infection, but GAS impetigo may also be a preceding infection.
  • Although pathogenicity is not completely understood, expert consensus implicates genetic and molecular mimicry leading to an inflammatory cascade as key to disease development.
  • Joint involvement is a likely result of immune complex accumulation.

Genetics

  • Susceptibility is associated with certain indigenous populations.
  • ARF is heritable, polygenic, and displays variable and incomplete penetrance.

Risk Factors

Poverty, household crowding, genetic susceptibility, ethnic predisposition, and social disadvantage are the strongest risk factors.

General Prevention

  • Primary prevention: Appropriate treatment of streptococcal infection prevents ARF in most cases (1).
  • Secondary prevention: long-term antibiotic prophylaxis (up to 5 to 10 years) to prevent recurrence (2)

There's more to see -- the rest of this topic is available only to subscribers.